MEDICAL DEVICE REGULATION IN US, EUROPE, CHINA AND INDIA
Journal Title: International Journal of Drug Regulatory Affairs - Year 2017, Vol 5, Issue 2
Abstract
Medical Device is an emerging market in last two decades since the use of medical device is escalating throughout the world. Millions of patients worldwide depend on Medical Device for the diagnosis & Management of diseases. Regulation of the Medical Device varies within the country are based on their own Regulatory bodies. In US Medical Devices are regulated by FDA- Centre for Devices & Radiological Health, in EU they are regulated by European Medical Agency, in China they are regulated by State Food & Drug Administration and in India they are regulated by Central Drug Standard Control Organization. Regulations of these countries and IMDRF, MDPWG were reviewed. Advantage of harmonizing regulations also reviewed.
Authors and Affiliations
Ganesh GNK, Lakshmi T. Vidhya
Keywords
Related Articles
- EP ID EP326713
- DOI 10.22270/ijdra.v5i2.198
- Views 151
- Downloads 0
A COMPREHENSION STUDY ON REGULATION OF HERBAL DRUGS IN USA, EUROPEAN UNION AND INDIA
The present study reviews the regulations of herbal drugs in the EU, US and India and throws light upon issues related to their clinical trials. Herbal drugs have been used for a long time in different systems of health...
Establishment of blending control for Hand operated Double Cone Blender
In the current study, a fundamental approach is used to establish operation procedure, for a hand operated double cone blender. Initially, assuming for a potent drug, where in, the strength of the drug is very less in t...
REGULATIONS OF ORPHAN DRUGS IN USA, EU AND INDIA-A COMPARATIVE STUDY
Orphan drugs are the drugs and natural products used in treatment, diagnosis, or prevention of rare disease. The orphan drug regulation varies in different countries. Initially a guideline (Orphan Drug Act) for orphan dr...
ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY: A REVOLUTIONIZED LC TECHNIQUE
High Performance Liquid Chromatography (HPLC) is a major technique for qualitative and quantitative drug analysis. More than 90% of drugs prescribed in official pharmacopoeias are being analyzed HPLC. HPLC analyzes the d...
Regulatory overview of biosimilars in Europe
A biosimilar is a biological medicine similar, but not identical, to an already registered reference bio therapeutic product in terms of quality, safety, and efficacy. These drugs are also called as biosimilar products„,...